Molecularly targeted drugs are those that act directly on a specific tumor area and preserve healthy cells. They attack specific characteristics of the malignant cells, making them a less aggressive treatment option for the organism and, in some cases, more efficient against the disease.
Yes, but the treatment causes fewer side effects in patients than chemotherapy, which usually causes vomiting, nausea, and hair loss. However, it is important to be aware of the possible adverse reactions of these drugs, which range from high blood pressure, diarrhea, and inflammation of the inside of the mouth and throat to skin changes.
No. They are two different treatment modalities that try to fight cancer more precisely and bring a better quality of life to the patient during therapy.
